Redwood AI Gains DTC Eligibility, Engages IBN for Investor Awareness Campaign
Redwood AI Corp. announced DTC eligibility for its common shares, simplifying U.S. trading and enhancing liquidity, while engaging InvestorBrandNetwork for a $114,000 market awareness campaign through September 2026.
Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) has achieved a significant milestone for its U.S. shareholders. The company announced that its common shares have been approved for electronic clearing and settlement through the Depository Trust Company (DTC), a move expected to simplify trading for U.S. investors and enhance the liquidity of the company's shares.
CEO Louis Dron emphasized the importance of DTC eligibility, stating that it improves access for U.S. investors and brokerage firms by enabling more efficient electronic clearing and settlement. This development is particularly crucial for companies listed on smaller exchanges, as it broadens the investor base and reduces friction in trading.
In a separate announcement, Redwood AI disclosed that it has engaged InvestorBrandNetwork (IBN) to provide market awareness, corporate communications, and digital media services. The engagement covers editorial coverage, newsletter distribution, social media support, and podcast syndication through Sept. 30, 2026, or until the allocated budget is exhausted. Redwood will pay IBN an aggregate cash fee of $114,000 for these services, with no securities issued as compensation. The full press release is available at https://ibn.fm/Yga70.
These announcements are strategically significant for Redwood AI, which uses advanced artificial intelligence to accelerate chemistry R&D, with applications in drug discovery and development, as well as defense and safety solutions. The company's platform combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up, enabling faster and more efficient development of new therapies and chemistry-driven applications. More information about Redwood AI can be found at https://redwoodai.com/.
DTC eligibility is often viewed by investors as a vote of confidence in a company's compliance and reporting standards, potentially leading to increased institutional interest and trading volume. For Redwood AI, this move could help attract more U.S. investors who were previously limited by the complexities of trading foreign securities. The engagement with IBN further underscores the company's commitment to raising its profile in the competitive AI and biotech sectors.
The broader implications of these developments are notable for the AI industry, particularly for companies focusing on chemistry and drug discovery. By improving its market accessibility and investor communications, Redwood AI is positioning itself to capitalize on the growing demand for AI-driven solutions in pharmaceuticals and defense. As the company continues to advance its platform, these strategic steps may pave the way for future partnerships and funding opportunities.